Organization
Center for Rheumatology and Bone Research, Wheaton
1 abstract
Abstract
A PHASE 2 STUDY OF MULTIPLE DOSES OF INTRAVENOUS POLYETHYLENE GLYCOL (PEG)-URICASE IN PATIENTS WITH HYPERURICEMIA AND TREATMENT-FAILURE GOUTOrg: Center for Rheumatology and Bone Research, Wheaton, Arthritis and Rheumatic Diseases, Oregon Health Sciences University, Portland, Arthritis Clinical Intervention Program, University of Alabama, Birmingham, Biostatistics, Clinical Operations, Savient Pharmaceuticals, Inc., East Brunswick, United States,